Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biopharmaceutical Analysis & Statistics in North America Countries, June 2012 (p7)

You might be interested in: biomedical, protein, antibody, more »

» Purchase Premium Reports

181-210 of about 300 reports
Genta Incorporated SWOT

Genta Incorporated SWOT

  • $ 175
  • Company report
  • June 2012
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Genta is a biopharmaceutical industry player engaged ...

  • Industries : Biopharmaceutical
  • Countries : United States
InterMune, Inc. SWOT

InterMune, Inc. SWOT

  • $ 175
  • Company report
  • June 2012
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. InterMune is a biotech industry player focused on ...

  • Industries : Biopharmaceutical
  • Countries : United States
Purchasing Trends in the Research Antibodies Market

Purchasing Trends in the Research Antibodies Market

  • $ 10 000
  • Industry report
  • May 2012
  • by Frost & Sullivan

This study is based on input from 1,155 laboratory personnel who either participate in their laboratory's purchase of antibodies or are users of antibodies. Most survey participants are located in the ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biosimilars: World Market Regulatory Update

Biosimilars: World Market Regulatory Update

  • $ 3 800
  • Industry report
  • May 2012
  • by Datamonitor

After consultation with market, the FDA published draft biosimilars guidelines in February 2012. Although details are lacking in a number of areas such as interchangeability, the guidance sets out the ...

  • Industries : Biopharmaceutical
  • Countries : World, Germany, Iran, Belgium, United States, United Kingdom, Europe
Proteus Biomedical, Inc. - Strategic SWOT Analysis Review

Proteus Biomedical, Inc. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2012
  • by Global Data

Proteus Biomedical, Inc. - Strategic SWOT Analysis Review Summary Proteus Biomedical, Inc. (Proteus) is a US-based medical device manufacturing company engaged in the development of intelligent medical ...

  • Industries : Biopharmaceutical
  • Countries : United States
9th Annual Report and Survey of Biopharmaceutical Manufacturing

9th Annual Report and Survey of Biopharmaceutical Manufacturing

  • $ 865
  • Industry report
  • May 2012
  • by BioPlan Associates, Inc.

Improve your decision-making in biomanufacturing capacity, production, and performance with this essential reference tool. With over 200 data graphs and tables with in-depth research on global biomanufacturers, ...

  • Industries : Biopharmaceutical
  • Countries : Europe, United States
Navidea Biopharmaceuticals, Inc. (NEOP) - Financial and Strategic SWOT Analysis Review

Navidea Biopharmaceuticals, Inc. (NEOP) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2012
  • by Global Data

Navidea Biopharmaceuticals, Inc. (NEOP) - Financial and Strategic SWOT Analysis Review Summary Navidea Biopharmaceuticals, Inc. (Navidea) is a biomedical company engaged in the development and commercialization ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical: Calypte Biomedical Corporation (CBMC)

Biopharmaceutical: Calypte Biomedical Corporation (CBMC)

  • $ 750
  • Company report
  • April 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Calypte Biomedical Corporation portfolio of new product development . The report provides detailed analysis on each pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States, Thailand, China
Enzymes: Canada : Focus report

Enzymes: Canada : Focus report

  • $ 850
  • Industry report
  • April 2012
  • by Freedonia Focus

This report discusses enzyme demand in Canada for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends and supply and demand ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Enzymes: Mexico : Focus report

Enzymes: Mexico : Focus report

  • $ 850
  • Industry report
  • April 2012
  • by Freedonia Focus

This report discusses enzyme demand in Mexico for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends and supply and demand ...

  • Industries : Biopharmaceutical
  • Countries : Mexico
SDIX (SDIX) - Financial and Strategic SWOT Analysis Review

SDIX (SDIX) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • March 2012
  • by Global Data

SDIX (formerly Strategic Diagnostics Inc.) is a biotechnology company engaged in developing, manufacturing and commercializing antibody products and analytical test kits utilized in agricultural, food, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Medical & Biological Laboratories Co., Ltd. (Symbol:4557) SWOT Analysis, Strategy, Revenues and Profits

Medical & Biological Laboratories Co., Ltd. (Symbol:4557) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Japan
Strategic Analysis of the U.S. Research Antibodies Market

Strategic Analysis of the U.S. Research Antibodies Market

  • $ 6 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pacgen Biopharmaceuticals Corporation (Symbol:PGA) SWOT Analysis, Strategy, Revenues and Profits

Pacgen Biopharmaceuticals Corporation (Symbol:PGA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Investment Confidence Among Laboratory Decision Makers

Investment Confidence Among Laboratory Decision Makers

  • $ 10 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

The study investigates investment decisions of healthcare-related laboratory decision makers. It shows that 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks only ...

  • Industries : Biopharmaceutical
  • Countries : United States
Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report

Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report

  • $ 125
  • Company report
  • March 2012
  • by ICD Research

Synopsis ICD Research's "Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report" contains in depth information and data about the company and its operations. ...

  • Industries : Biopharmaceutical
  • Countries : United States
Burcon NutraScience Corporation: Ingredients Company Profile, SWOT & Financial Report

Burcon NutraScience Corporation: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "Burcon NutraScience Corporation: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Cereal Production, Biopharmaceutical
  • Countries : Canada
BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report

BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Biopharmaceutical
  • Countries : Canada
SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile

SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile Summary SunOpta BioProcess Inc. (SunOpta) is engaged in designing, construction and operation of biomass conversion equipments. ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Merger & Acquisition in Medical Equipment Industry: Omrix Biopharmaceuticals, Inc.

Merger & Acquisition in Medical Equipment Industry: Omrix Biopharmaceuticals, Inc.

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • February 2012
  • by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
US Fat Replacers Industry

US Fat Replacers Industry

  • $ 4 500
  • Industry report
  • February 2012
  • by Global Industry Analyst

This report analyzes the US market for Fat Replacers in Thousand Metric Tons and US$ Million by the following Product Segments: Carbohydrate-Based Fat Replacers (Starch-Based Fat Replacers, & Hydrocolloid-Based ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : United States
Biopharmaceutical Industry: Nabi Biopharmaceuticals - Strategy and SWOT Report

Biopharmaceutical Industry: Nabi Biopharmaceuticals - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

The Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, operation, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nabi Biopharmaceuticals

Nabi Biopharmaceuticals

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

Nabi Biopharmaceuticals - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nabi Biopharmaceuticals SWOT

Nabi Biopharmaceuticals SWOT

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Nabi Biopharmaceuticals (Nabi) is engaged in the ...

  • Industries : Biopharmaceutical
  • Countries : United States
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market Summary GBI Research, the leading business ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Europe
Enzymes: United States : Focus report

Enzymes: United States : Focus report

  • $ 600
  • Industry report
  • December 2011
  • by Freedonia Focus

Report Description This report discusses US enzyme demand for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product and market segmentation, environmental and regulatory ...

  • Industries : Biopharmaceutical
  • Countries : United States
Next-Generation Antibody Therapies: Pipeline and Market 2011-2021

Next-Generation Antibody Therapies: Pipeline and Market 2011-2021

  • $ 2 621
  • Industry report
  • November 2011
  • by Visiongain

Report Details What are the prospects for emerging antibody technologies? Visiongain's report shows you potential revenues to 2021, discussing R&D trends and opportunities.  A new generation of therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : United States
Dyax Corporation SWOT

Dyax Corporation SWOT

  • $ 175
  • Company report
  • October 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Dyax, a development stage biopharmaceutical firm ...

  • Industries : Biopharmaceutical
  • Countries : United States
Celgene Corporation SWOT

Celgene Corporation SWOT

  • $ 175
  • Company report
  • October 2011
  • by MarketLine

Celgene Corporation - SWOT Analysis industry player profile is the essential source for top-level industry player data and information. The market research report examines the firm ?s key business structure ...

  • Industries : Biopharmaceutical
  • Countries : United States

» View Public Reports

About 500 reports

The United States: Brief Outlook, 2014, focus on Monoclonal Antibody

  • Country report
  • March 2014
  • 2 pages

... Is wholesale acquisition cost (wac), or the list price for a drug sold by a manufactu to wholesalers. The 2010 wac for 50 mg of palivizumab was $1074. For alaska medicaid spe- cifically, the reported pre ...


» Read our Company Profiles

7 Companies

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

Merck KGaA

Germany

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.